Article
<i>In vitro</i> evolution of Remdesivir resistance reveals genome plasticity of SARS-CoV-2
2021-02-10
Abstract excerpt
Remdesivir (RDV) is used widely for COVID-19 patients despite varying results in recent clinical trials. Here, we show how serially passaging SARS-CoV-2 in vitro in the presence of RDV selected for drug-resistant viral populations. We determined that the E802D mutation in the RNA-dependent RNA polymerase was sufficient to confer decreased RDV sensitivity without affecting viral fitness. Analysis of more than 200,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6d719dd5-6e17-53de-9435-978b9f5ce7b8
- DOI
- 10.1101/2021.02.01.429199
